UBE2C and breast cancer: Existing articles have reported that ubiquitin-conjugating enzyme E2C (UBE2C) (Morikawa et al., 2013), ubiquitin-like with PHD and ring-finger domains 1 (UHRF1), nuclear matrix protein22 (NMP-22), human complement factor H-related protein (Unoki et al., 2009), leucine-rich and immunoglobulin-like domains (LRIGs), and asymptomatic microhematuria (AMH) (Soria et al., 2019) are potential prognostic or diagnostic markers of BC.